دورية أكاديمية
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study
العنوان: | Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study |
---|---|
المؤلفون: | Ogdie, AlexisAff1, IDs41927024003867_cor1, Merola, Joseph F., Mease, Philip J., Ritchlin, Christopher T., Scher, Jose U., Lafferty, Kimberly Parnell, Chan, Daphne, Chakravarty, Soumya D.Aff6, Aff7, Langholff, Wayne, Wang, Yanli, Choi, Olivia, Krol, Yevgeniy, Gottlieb, Alice B. |
المصدر: | BMC Rheumatology. 8(1) |
قاعدة البيانات: | Springer Nature Journals |
كن أول من يترك تعليقا!